OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
December 02, 2022
Linkam Scientific Instruments’ NEXUS software enables holistic environmental controls in experiments.
December 01, 2022
Catalent has completed the expansion of its clinical supply facility located in Shanghai, China.
November 30, 2022
The agreement will see Immutep and Merck KGaA, Darmstadt, Germany jointly fund the INSIGHT-005 study.
November 29, 2022
Webinar Date/Time: Thursday, December 8, 2022 at 11am EST | 10am CST | 8 am PST
November 22, 2022
The $286 million investment ability is designed to elevate MillioporeSigma’s ability to conduct biosafety testing and analytical development services.
Webinar Date/Time: Mon, Dec 12, 2022 11:00 AM EST
November 21, 2022
Element has opened a new 7500-ft3 facility that will be used to evaluate aerosolized product efficacy for reducing airborne organisms and viral particles.
November 17, 2022
CellVax Therapeutics has selected Theragent, a new CDMO, to manufacture clinical trial material for a new Phase II prostate cancer immunotherapy drug candidate.
November 14, 2022
The new facility will allow ReiThera to consolidate its competitive position as a leading CDMO specialized in viral vector production.
Avantor is continuing its investment to support the biopharma market with the opening of its new distribution center in Dublin, Ireland.